vax161
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2012 (NCT01560793)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- vax161
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01658800 | Phase 1 | Sep 1, 2012 | VaxInnate Corporation |
| NCT01560793 | Phase 1 | Jun 1, 2012 | Johnson County Clin-Trials, MRA Clinical Research, VaxInnate Corporation |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| VaxInnate Corporation | For profit | 2 | 2 | 1 | 2012 |
| Johnson County Clin-Trials | For profit | 1 | 0 | 1 | 2012 |
| MRA Clinical Research | Academic/Hospital | 1 | 0 | 1 | 2012 |
3 organizations
Page 1 / 1